Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Device Maker To Buy Australia’s HeartWare For U.S.$282 Million

This article was originally published in PharmAsia News

Executive Summary

U.S. medical-device maker Thoratec Cor plans to buy Australia's HeartWare for $282 million and a $28 million loan. HeartWare makes an implantable heart pump, HeartMate II, for patients with heart failure, already marketed in Europe and awaiting U.S. FDA approval. HeartWare also markets a heart device the size of a D-cell battery. Thoratec CEO Gary Burbach said the deal combines HeartWare's innovative products with Thoratec's devices. The pump, considered one of the world's smallest, already has U.S. clearance for patients awaiting transplants. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel